Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

ClinicalTrials.gov ID: NCT01416441

Public ClinicalTrials.gov record NCT01416441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 8:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of the current trial is to obtain long term efficacy, safety and tolerability data of once weekly aripiprazole in children and adolescents with Tourette's Disorder.

Study identification

NCT ID
NCT01416441
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
170 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
7 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2011 (Actual)
Primary completion
Mar 13, 2014 (Actual)
Completion
Mar 13, 2014 (Actual)
Last update posted
Oct 7, 2021

2011 – 2014

United States locations

U.S. sites
36
U.S. states
20
U.S. cities
34
Facility City State ZIP Site status
Not listed Dothan Alabama 36303 —
Not listed Little Rock Arkansas 72205 —
Not listed Los Angeles California 90095 —
Not listed Sacramento California 95815 —
Not listed San Diego California 92108 —
Not listed San Francisco California 94143 —
Not listed Santa Ana California 92701 —
Not listed Wildomar California 92595 —
Not listed Gainesville Florida 32610 —
Not listed Hialeah Florida 33012 —
Not listed Miami Florida 33126 —
Not listed Orange City Florida 32763 —
Not listed St. Petersburg Florida 33701 —
Not listed Atlanta Georgia 30308 —
Not listed Atlanta Georgia 30329 —
Not listed Chicago Illinois 60612 —
Not listed Indianapolis Indiana 46202-5200 —
Not listed Overland Park Kansas 66211 —
Not listed New Orleans Louisiana 70114 —
Not listed Bloomfield Hills Michigan 48302 —
Not listed Omaha Nebraska 68131 —
Not listed Manhasset New York 11030 —
Not listed Staten Island New York 10312 —
Not listed Avon Lake Ohio 44012 —
Not listed Cincinnati Ohio 45229-3039 —
Not listed Cleveland Ohio 44106 —
Not listed Middleburg Heights Ohio 44130 —
Not listed Oklahoma City Oklahoma 73112 —
Not listed Philadelphia Pennsylvania 19139 —
Not listed Dallas Texas 75230 —
Not listed San Antonio Texas 78229 —
Not listed San Antonio Texas 78258 —
Not listed Salt Lake City Utah 84106 —
Not listed Charlottesville Virginia 22903 —
Not listed Bothell Washington 98011 —
Not listed La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01416441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 7, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01416441 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →